Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Combining genome-wide CRISPR screens and microfluidics to discover genetic regulators during the differentiation pathway towards transplantable hematopoietic stem cells

EF 2018-19

Résumé
Stem cells have the ability to become nearly any cell type in the human body. Therefore, they have tremendous potential to be used in the treatment of disease. For example, stem cells can be used to generate healthy blood and bone cells for cancer patients. Currently this is done using bone marrow transplants. However, there are outstanding issues with this treatment. These include difficulties finding a suitable donor and complications such as rejection of the new cells, infection, or reoccurrence of the disease. In fact, nearly 30% of transplant patients die within one year of the treatment. My research aims to provide a better alternative -- turning a patient's own skin cells into stem cells and then blood. This would eliminate the need for a donor and reduce the likelihood of complications resulting in death. To do this I am leveraging a new gene-editing tool, called CRISPR, to search for genes that control the differentiation of stem cells. I am also engineering a platform based on micro-scale fluidic chips which can sort billions of cells using magnetic nanoparticles. This platform allows the search to cover more of the human genome, take less time and be less expensive. This approach has the additional potential to treat other diseases by identifying genes that could tell stem cells to become heart or brain cells.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
396611
Name
Philpott David N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Combining genome-wide CRISPR screens and microfluidics to discover genetic regulators during the differentiation pathway towards transplantable hematopoietic stem cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Bone Marrow; Cell Sorting; Cellular Therapy; Crispr; Cytometry; Genetic Screen; Microfluidics; Nano; Regenerative Medicine; Stem Cells
Abstract
Stem cells have the ability to become nearly any cell type in the human body. Therefore, they have tremendous potential to be used in the treatment of disease. For example, stem cells can be used to generate healthy blood and bone cells for cancer patients. Currently this is done using bone marrow transplants. However, there are outstanding issues with this treatment. These include difficulties finding a suitable donor and complications such as rejection of the new cells, infection, or reoccurrence of the disease. In fact, nearly 30% of transplant patients die within one year of the treatment. My research aims to provide a better alternative -- turning a patient's own skin cells into stem cells and then blood. This would eliminate the need for a donor and reduce the likelihood of complications resulting in death. To do this I am leveraging a new gene-editing tool, called CRISPR, to search for genes that control the differentiation of stem cells. I am also engineering a platform based on micro-scale fluidic chips which can sort billions of cells using magnetic nanoparticles. This platform allows the search to cover more of the human genome, take less time and be less expensive. This approach has the additional potential to treat other diseases by identifying genes that could tell stem cells to become heart or brain cells.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Philpott, David N
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~